Key points for development of immunotherapy for cancer using T cell defined tumor antigens

Y. Kawakami

Research output: Contribution to journalArticle

Abstract

New immunotherapies using cancer antigens recognized by T-cells have recently been developed and a variety of phase I clinical trals has been conducted in the US and Europe. An anti-tumor effect has already been observed in some protocols. However, many questions still remain to establish effective immunotherapies for cancer. Key points which were raised in the research on immunotherapies against melanoma are discussed in this article.

Original languageEnglish
Pages (from-to)429-433
Number of pages5
JournalBiotherapy
Volume13
Issue number5
Publication statusPublished - 1999 Jun 26

Keywords

  • Cancer antigens
  • Dendritic cells
  • Immunotherapy
  • Peptides
  • T-cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Key points for development of immunotherapy for cancer using T cell defined tumor antigens'. Together they form a unique fingerprint.

  • Cite this